Active Ingredient History

  • Now
Ranirestat is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.   Wikipedia

  • SMILES: Fc1cc(Br)ccc1CN2C(=O)c3cccn3[C@@]4(CC(=O)NC4=O)C2=O
  • Mol. Mass: 420.19
  • ALogP: 1.31
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-4-spiro-3'-pyrrolidine-1.2',3,5'-tetrone | as 3201 | as-3201 | ranirestat | sx 3030 | sx-3030 | sx 3202 | sx-3202


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue